Dr. West speaks with Dr. Suzanne Dahlberg about her path into biostatistics, leadership in shaping trials with ECOG & Dana Farber Cancer Institute, & changing endpoints & trial designs in an era of molecular oncology. (31:36)
Drs. Jack West & Corey Langer debate the criteria for adopting early clinical data as practice-changing as immunotherapy trials in locally advanced & metastatic NSCLC are reported. (19:05)
